Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 26,651 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CTRL Clear all

Conditions: Digestive Discomfort
Interventions: Dietary Supplement: conventional cow's milk consumption, and then A1PF milk consumption, Dietary Supplement: A1PF milk consumption, and then conventional cow's milk consumption; Other
Lead sponsor: a2 Milk Company Ltd.; Industry
Eligibility: 18 Years to 68 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Healthy Volunteers
Interventions: Placebo, Roflumilast/Sitagliptin, Sitagliptin, Roflumilast; Other
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 21 Years to 55 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Eosinophilic Esophagitis
Interventions: AQ280 Capsule, AQ280 Tablet for Oral Suspension, Placebo Capsule, Placebo Tablet for Oral Suspension; Drug
Lead sponsor: AQILION AB; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Parkinson's Disease
Interventions: Donepezil, Placebo; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Overweight, Obesity
Interventions: Brief Consultation with Health Counselor, workbook, Usual Care wait list; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 69 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Stanford, California

Conditions: Generalized Anxiety Disorder
Interventions: Placebo, Vortioxetine, Duloxetine; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 781 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 66
States / cities: Anaheim, California • Beverly Hills, California • Fresno, California + 63 more

Conditions: Speech Sound Disorder
Interventions: Biofeedback-ultrasound, Biofeedback--visual-acoustic, Traditional articulation treatment; Behavioral
Lead sponsor: New York University; Other
Eligibility: 9 Years to 15 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Bloomfield, New Jersey • Syracuse, New York

Conditions: Epiphora
Interventions: Atropine sulfate ophthalmic solution 0.005%, Vehicle arm; Drug
Lead sponsor: Rehan Ahmed; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Houston, Texas • Mesquite, Texas

Conditions: Spinal Cord Injury
Interventions: TESS, Training, Motor Task, sham-TESS; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Hines, Illinois

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: Patient education; Behavioral
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Migraine
Interventions: Rimegepant, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 962 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 23
States / cities: Los Angeles, California • Sherman Oaks, California • Stamford, Connecticut + 20 more

Conditions: Lipidemia, Coronary Artery Disease, Plaque, Atherosclerotic
Interventions: obicetrapib 10 mg + ezetimibe 10 mg FDC daily, Placebo; Drug · Other
Lead sponsor: NewAmsterdam Pharma; Industry
Eligibility: 45 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Hialeah, Florida

Conditions: Precancerous Condition, Stage 0 Melanoma, Stage I Melanoma, Stage II Melanoma
Interventions: lovastatin, placebo, biopsy, laboratory biomarker analysis; Drug · Other · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: Orange, California • Tampa, Florida • Salt Lake City, Utah

Conditions: Endometriosis, Infertility
Interventions: Leuprolide acetate in depot suspension, No intervention; Drug · Other
Lead sponsor: Colorado Center for Reproductive Medicine; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Lone Tree, Colorado

Conditions: Osteoarthritis, Knee
Interventions: Botulinum toxin type A (Btx-A), Cortisone; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Urinary Incontinence
Interventions: Retzius sparing radical prostatectomy, Vattikuti Urology Institute radical prostatectomy, da Vinci Surgical System; Procedure · Device
Lead sponsor: Henry Ford Health System; Other
Eligibility: 40 Years to 75 Years · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 2
States / cities: Detroit, Michigan • West Bloomfield, Michigan

Conditions: Pain
Interventions: ALGRX 3268; Drug
Lead sponsor: AlgoRx Pharmaceuticals; Industry
Eligibility: 3 Years to 18 Years
Enrollment: 504 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obesity
Interventions: Weight-loss and weight-maintenance diets; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Type 2 Diabetes
Interventions: Routine Care + Glycemic Excursion Minimization (RC+GEM), Routine Care (RC); Behavioral · Other
Lead sponsor: Chiara Fabris, PhD; Other
Eligibility: 30 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Aurora, Colorado • Charlottesville, Virginia

Conditions: Tobacco Use
Interventions: Anti-vaping and anti-smoking digital advertising; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 2,800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Food Selection, Food Preferences, Behavior, Eating
Interventions: Simulated grocery shopping exercise; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 1,185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes Mellitus, Type 1
Interventions: Empagliflozin, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 977 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 39
States / cities: Montgomery, Alabama • Concord, California • Fresno, California + 33 more

Conditions: Healthy
Interventions: 1 mg, 5 mg, 10 mg; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Culver City, California • Glendale, California

Conditions: Pregnancy Related
Interventions: technology-based program; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

A1 Beta-casein-free Milk in Milk-intolerant Participants

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation

The Effect of Donepezil on Gait and Balance in Parkinson's Disease

Study to Promote Physical Activity Among Overweight Persons

Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Correcting Residual Errors With Spectral, Ultrasound, Traditional Speech Therapy

Low-Dose Atropine Eye Drops for Excessive Tearing (Epiphora)

Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia

Eye on Diabetes: A Multidisciplinary Patient Education Intervention

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque

Lovastatin in Treating Patients At High Risk of Melanoma

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

Is Botox Effective in Relieving Pain From Knee Osteoarthritis?

Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery

Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.

Substituting Mushrooms for Meat to Control Body Weight

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

Digital Media for Cancer Control (to Prevent Vaping and Smoking Behavior)

Effect of Gamification in an Online Grocery Store.

Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)

Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

Bringing Education Through Technology, Empathic Listening, and Research